Diferelin (triptorelin) powder 0.1 mg. injections №7


Manufacturer: Slovenia



Prostate cancer. Treatment of locally prostate cancer separately or as a concomitant and adjuvant therapy in combination with radiotherapy. Treatment of metastatic prostate cancer. The desired effect of treatment is most pronounced and is observed more often if the patient has not undergone other hormone therapy before. Genital and extragenital endometriosis (stages I-IV). Therapy should be carried out for longer than 6 months. A repeat course of triptorelin or another gonadotropin-releasing hormone (GnRH) analogue is not recommended. Female infertility. Complex treatment in combination with gonadotropins (human menopausal gonadotropin (hMG), follicle-stimulating hormone (FSH), chorionic gonadotropin (hCG)), for artificial reproduction of ovulation conditions, for in vitro fertilization and subsequent embryo transplantation (IVFET). Premature puberty in children (girls under 8 yEars and Nose of age and boys under 10 yEars and Nose of age). Breast cancer when hormone therapy is indicated. Treatment of uterine fibromyoma before surgery: due to anemia (hemoglobin level below or equal to 8 g / DL) as an auxiliary and corrective drug for surgical treatment in case of need to reduce the size of fibromyoma: endoscopic surgery, transvaginal surgery. The duration of treatment is limited to three months.